The two organizations have been working together for 10 years to deliver
world-class clinical development services to Chiltern's broad customer
base via the
Known for its collaborative approach designed around its clients, Chiltern offers comprehensive programs and functional service provisions (FSP) to the global pharmaceutical, biotechnology and device markets. The organization has deep experience in oncology, dermatology, endocrine and metabolic, gastroenterology, respiratory, ophthalmology and neuroscience, among others — enabling its 4,300+ staff to fold unique therapeutic expertise into its wide range of clinical development and data and analytics services.
In its 35 years of operations, Chiltern has spent the last decade
bolstering its R&D and scientific expertise with Medidata's unified
technology platform. Chiltern joined Medidata's Partner Program in 2007,
when it became accredited in Medidata's industry-leading electronic data
capture, management and reporting tool,
"As the global life sciences landscape continues to evolve, it's
important that Chiltern aligns itself with innovative technology
partners that have the agility, scale and insight to meet the most
rigorous aspects of clinical development today—from real-time analytics
to risk-based monitoring, biometrics and pharmacovigilance.
"Medidata's extensive partnership with Chiltern reflects our shared
commitment to marrying cutting-edge technology, data-driven processes
and scientific excellence to develop better therapies for patients,"
Chiltern was the winner of Medidata's inaugural "Architect
of Hope" Award in 2016, an award in recognition of the CRO's
successful partnership with a major biopharmaceutical company. The
organization will continue to use Medidata's study conduct solutions and
patient engagement tools in a number of its upcoming studies, as well as
tap into Medidata's latest mobile health (mHealth) offering,
Attending the DIA 2017 Annual Meeting in
Chiltern, a global contract research organization, is a leading provider of clinical services and solutions in a variety of therapeutic areas with engagement models for biopharmaceutical and medical device industries. Chiltern's team of more than 4,300, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance and Strategic Regulatory services using a collaborative approach for more efficient clinical trials. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®.
The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 18 of the world's top 25 global pharmaceutical companies and is used by 18 of the top 25 medical device developers—from study design and planning through execution, management and reporting.
Anthony D'Amico, +1 732-767-4331
News Provided by Acquire Media